Ovoca Bio | OVG - Marktkapitalisierung

Aktienkurs
7.75
Täglich Wechseln
0 0%
Monatlich
-24.39%
Jährlich
84.52%
Q1 Prognose
7.51




Marktkapitalisierung Veränderung Datum
Akebia Therapeutics USD 312M 115M 2026-03
Alaunos Therapeutics USD 51M 46M 2026-03
ALKERMES USD 4.47B 146M 2026-03
Avita Medical AUD 164.6M 59.13M 2026-03
Dianthus Therapeutics USD 2.32B 535M 2026-03
Great Western Mining Corporation EUR 4.05M 420.79K 2023-06
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Malin Corporation EUR 142.92M 19.65M 2026-02
Organon & Co USD 1.86B 916.43M 2025-12
Ovoca Bio EUR 7.54M 4.28M 2022-06
Revvity USD 10.97B 1.21B 2025-12
Tectonic Therapeutic USD 474M 84M 2026-03
Viatris USD 14.34B 2.8B 2025-12
Xeris Pharmaceuticals USD 788M 515M 2026-03